A CRISPR-Cas9 knockout screening identifies IRF2 as a key driver of OAS3/RNase L-mediated RNA decay during viral infection
Proceedings of the National Academy of Sciences · 05.11.2024 · 121 (45)
DOI: 10.1073/pnas.2412725121 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 30.10.2024. Verfasst von Sunwoo Oh und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Chemistry, School of Medicine, University of California, Irvine, CA 92697. Hauptthemen laut MEDLINE: CRISPR-Cas Systems, Interferon Regulatory Factor-2, Endoribonucleases, 2',5'-Oligoadenylate Synthetase. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: American Cancer Society (ACS), NIAID NIH HHS, HHS | National Institutes of Health (NIH).
Abstract (Originalsprache)
OAS-RNase L is a double-stranded RNA-induced antiviral pathway triggered in response to diverse viral infections. Upon activation, OAS-RNase L suppresses virus replication by promoting the decay of host and viral RNAs and inducing translational shutdown. However, whether OASs and RNase L are the only factors involved in this pathway remains unclear. Here, we develop CRISPR-Translate, a FACS-based genome-wide CRISPR-Cas9 knockout screening method that uses translation levels as a readout and identifies IRF2 as a key regulator of OAS3. Mechanistically, we demonstrate that IRF2 promotes basal expression of OAS3 in unstressed cells, allowing a rapid activation of RNase L following viral infection. Furthermore, IRF2 works in concert with the interferon response through STAT2 to further enhance OAS3 expression. We propose that IRF2-induced RNase L is critical in enabling cells to mount a rapid antiviral response immediately after viral infection, serving as the initial line of defense. This rapid response provides host cells the necessary time to activate additional antiviral signaling pathways, forming secondary defense waves.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biological Chemistry, School of Medicine, University of California, Irvine, CA 92697.
- Department of Microbiology and Molecular Genetics, School of Medicine, University of California, Irvine, CA 92697.
ORCID-Profile: Sunwoo Oh, Gisselle Santiago, Junyi Li, Bert L Semler, Rémi Buisson
Förderung
- American Cancer Society (ACS)
- NIAID NIH HHS
- HHS | National Institutes of Health (NIH)
- NCI NIH HHS
Zitieren
APA
Oh, S., Santiago, G., Manjunath, L., Li, J., Bouin, A., Semler, B. L., & Buisson, R. (2024). A CRISPR-Cas9 knockout screening identifies IRF2 as a key driver of OAS3/RNase L-mediated RNA decay during viral infection. Proceedings of the National Academy of Sciences, 121(45). https://doi.org/10.1073/pnas.2412725121
Vancouver
Oh S, Santiago G, Manjunath L, Li J, Bouin A, Semler BL, et al. A CRISPR-Cas9 knockout screening identifies IRF2 as a key driver of OAS3/RNase L-mediated RNA decay during viral infection. Proceedings of the National Academy of Sciences. 2024;121(45). doi:10.1073/pnas.2412725121
BibTeX
@article{Oh2024,
author = {Oh, Sunwoo and Santiago, Gisselle and Manjunath, Lavanya and Li, Junyi and Bouin, Alexis and Semler, Bert L and Buisson, Rémi},
title = {A CRISPR-Cas9 knockout screening identifies IRF2 as a key driver of OAS3/RNase L-mediated RNA decay during viral infection},
journal = {Proceedings of the National Academy of Sciences},
year = {2024},
volume = {121},
number = {45},
doi = {10.1073/pnas.2412725121}
}
EUVIMED